ResearchMoz

Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014

GlobalData
Published Date » 2014-07-21
No. Of Pages » 67
Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014  Summary  GlobalData's clinical trial report, Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Lumbar Spinal Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lumbar Spinal Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lumbar Spinal Stenosis. This report is built using data and information sourced from proprietary...
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Lumbar Spinal Stenosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Lumbar Spinal Stenosis 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Lumbar Spinal Stenosis Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Sucampo Pharmaceuticals, Inc. 28
Clinical Trial Overview of Sucampo Pharmaceuticals, Inc. 28
United Therapeutics Corporation 29
Clinical Trial Overview of United Therapeutics Corporation 29
Mesoblast Limited 30
Clinical Trial Overview of Mesoblast Limited 30
KT&G Corporation 31
Clinical Trial Overview of KT&G Corporation 31
Kaken Pharmaceutical Co., Ltd. 32
Clinical Trial Overview of Kaken Pharmaceutical Co., Ltd. 32
Clinical Trial Overview of Top Institutes / Government 33
Keio University 33
Clinical Trial Overview of Keio University 33
Hamamatsu University School of Medicine 34
Clinical Trial Overview of Hamamatsu University School of Medicine 34
National University Of Health Sciences 35
Clinical Trial Overview of National University Of Health Sciences 35
University of Manitoba 36
Clinical Trial Overview of University of Manitoba 36
Asan Medical Center 37
Clinical Trial Overview of Asan Medical Center 37
Kobe University 38
Clinical Trial Overview of Kobe University 38
Yonsei University 39
Clinical Trial Overview of Yonsei University 39
Ohio State University 40
Clinical Trial Overview of Ohio State University 40
Leiden University Medical Center 41
Clinical Trial Overview of Leiden University Medical Center 41
Emory University 42
Clinical Trial Overview of Emory University 42
Five Key Clinical Profiles 43
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 67

List of Tables
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Lumbar Spinal Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Lumbar Spinal Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Lumbar Spinal Stenosis Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Lumbar Spinal Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sucampo Pharmaceuticals, Inc., 2014* 28
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014* 29
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mesoblast Limited, 2014* 30
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by KT&G Corporation, 2014* 31
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaken Pharmaceutical Co., Ltd., 2014* 32
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2014* 33
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamamatsu University School of Medicine, 2014* 34
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Of Health Sciences, 2014* 35
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014* 36
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014* 37
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2014* 38
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 39
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University, 2014* 40
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014* 41
Lumbar Spinal Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 42

List of Figures
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Lumbar Spinal Stenosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Lumbar Spinal Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Lumbar Spinal Stenosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Lumbar Spinal Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Lumbar Spinal Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Lumbar Spinal Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Lumbar Spinal Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 66

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Fuel Ethanol Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
The global fuel ethanol market is experiencing tremendous growth due to the increasing use of ethanol in the end-use market. Its usage is being encouraged due to the ban on gasoline in most of the countries. It is replacing other vehicular fuels and also being used as an additive along with petroleum products. Incredible hike in crude oil prices, and increased green house gas emissions are encouraging governments to promote consumption of ethanol.   Ethanol finds numerous industrial applications as Pharmaceutical Chemical Feedstock Beverage...
Rubber Processing Chemicals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
By - Transparency Market Research
Rubber is a polymer which is majorly classified as natural rubber and synthetic rubber. Natural rubber only contains the monomers of isoprene whereas; the synthetic rubber may contain different types of monomers. Natural rubber is coagulated latex obtained from certain types of trees that are grown in the tropics. Whereas, synthetic rubber is obtained by mixing butadiene and styrene which are two by-products of petroleum refining. About 70% of rubber consumed belongs to the category of synthetic rubbers. Manufacturers of synthetic rubbers can adapt to different chemical...
Solid State Transformers (SST) market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast, 2014 - 2020
By - Transparency Market Research
A major infiltration of renewable energy generation into the existing generation mix within the next few years is likely to trigger the solid state transformers (SST) market.  These transformers, composed of mainly power electronics based components can also be referred to as a type of power device. These devices are extremely effective in regulating the magnitude of voltage, current or frequency according to the application wise requirements. New technology proliferation in power electronics has significantly reduced the size of these transformers hence making them...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Technology License Deal Signed between Sumitomo Chemical and Universal Display
Jan 22, 2015  
A new OLED technology license agreement has been signed between Sumitomo Chemical Company Ltd., and Universal Display Corporation. This agreement states that non-exclusive license rights have been granted to Sumitomo Chemical by Universal Display. These rights come within the ambit of several patents that are controlled and owned by Universal Display for manufacturing and selling processed...
Utah: Ranks No. 2 in Toxic Chemical Emissions
Jan 22, 2015  
As per reports, it has been observed and concluded that Utah has the maximum number of open-pit copper mines in the entire world, and this involves huge volumes of lead compounds. The annual inventory of Environmental Protection Agency denotes that Utah holds the second position amidst 56 states and territories all over the country for toxic and harmful releases per square mile. ...
The Production of Bio-based Materials and Chemicals to Increase Significantly by 2018
Jan 22, 2015  
It is expected that the global production capacity of bio-based materials and chemicals will increase significantly by 2018. The growth will primarily be driven by growth taking place in Brazil, and the U.S. As a result, with the help of the emerging technologies the production will be greater than 7.4 million metric tons. Also, the market for bio-based materials and chemicals will be fueled...
Maxx Mobilink Announces its Plan to Manufacture in India
Jan 22, 2015  
Maxx Mobilink, Indian smartphone manufacturer intends to start making mobile handsets at its Haridwar plant. This plan will only materialize after the manufacturer has assembled devices starting April at its factory where it presently makes charger, batteries, and other such accessories. The mobile manufacturer’s plan is in accordance with Prime Minister’s appeal to the nation to...
Ontario to Benefit from Western Canadas Loss
Jan 22, 2015  
As oil prices are hitting a new low in Canada, the country cannot help but turn to Ontario to make some recovery. Presently, Ontario is Canada’s only hope to sustain its growth in manufacturing. It was in December last year that TD Economics predicted that Ontario will help Canada achieve growth at a rapid pace with a 2.6% hike in GDP in 2015. The current economic winds are suggestive of...